NCT05642624View on ClinicalTrials.gov

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

June 28, 2022

Study Completion Date

June 28, 2022

Conditions
Fungal Infection
Interventions
DRUG

Deoxycholic acid amphotericin B

Starting with 1mg and increasing by 5-25mg daily until the maintenance dose is 50mg/d.

Trial Locations (2)

210009

Zhongda Hospital, Southeast University, Nanjing

Zhongda Hospital, Nanjing

All Listed Sponsors
lead

Southeast University, China

OTHER

NCT05642624 - The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock | Biotech Hunter | Biotech Hunter